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Dental amalgam and mercury in dentistry
AJ Spencer*
Abstract
Mercury in dentistry has re-emerged as a
contentious issue in public health, predominantly
because so many people are inadvertently exposed
to mercury in order to obtain the benefits of dental
amalgam fillings, and the risks remain difficult to
interpret. This commentary aims to examine the
issues involved in public policy assessment of the
continued use of dental amalgam in dentistry. More
than 30 per cent of Australian adults are concerned
about mercury from dental amalgam fillings but
only a small percentage report having their
amalgam fillings removed. The placement of dental
fillings nearly halved between 1983 and 1997, but
many millions of dental amalgam fillings exist in the
Australian community. These fillings release
mercury (mercury vapour or inorganic ions) at a low
level (about 2-5µg/day in an adult). Evidence on the
health effect of dental amalgams comes from
studies of the association between their presence
and signs or symptoms of adverse effects or health
changes after removal of dental amalgam fillings.
More formal risk assessment studies focus on
occupational exposure to mercury and health
effects. Numerous methodological issues make
their interpretation difficult but new research will
continue to challenge policymakers. Policy will also
reflect prudent and cautious approaches, encour-
aging minimization of exposure to mercury in
potentially more sensitive population groups. Wider
environmental concerns and decreasing tolerance
of exposure to other mercury compounds (for
example, methylmercury in seafoods) will ensure
the use of mercury in dentistry remains an issue,
necessitating dentists keep their patients informed
of health risks and respect their choices.
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attention of national health authorities in Australia
in 1999.1,2 Given the substantial differences in their
roles in dentistry, it may at first seem surprising that
these are regarded as such contentious issues.
However, they share characteristics that might help
explain the attention they receive:
1. Fluoride and mercury are widespread in the
natural environment.
2. When high levels of exposure occur, adverse
health effects have been observed.
3. Fluoride in water and mercury vapour at low
concentrations are colourless, tasteless and odour-
less, making it difficult to know if they’re present or
to what extent.
4. What is known is that very large numbers of
people are deliberately or inadvertently exposed to
each substance. Two-thirds of the Australian com-
munity live in fluoridated areas and possibly a
greater proportion of people have or have had dental
amalgam restorations.
5.While the benefits are self-evident to many, it is
a view not shared by all.
6. Their use involves assessments about benefits
and risks which are not always easily quantified.
7. There is an increasing volume of research
literature relevant to the assessment of benefits and
risks which leads to different interpretations. A vocal
minority in the community uses differing inter-
pretations to justify calls for changes in public policy.
The purpose of this commentary is to provide an
overview of the assessment of dental amalgam and
mercury in dentistry – it is not a literature review.
Detailed discussion has recently been published2 and
a systematic review is currently underway as part of
a further risk assessment by the National Health and
Medical Research Council. This commentary aims
to examine the issues involved in public policy
assessment of the continued use of dental amalgam
in dentistry.
Public opinion
All dentists in Australia are aware that some of
their patients have concerns about dental amalgam
Introduction
Water fluoridation and the use of mercury in
dental amalgam attracted, not for the first time, the
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fillings and mercury. Just how often patients raise
these concerns with Australian dentists is unknown.
While researchers in Scandinavia sought information
on patients’ concerns through surveys of dentists,3
no such study has been conducted in Australia.
Alternatively, such information may be sought
directly from the public. In 1995, 5,101 people were
interviewed by telephone on their access to dental
care. A random sub-sample of the adults interviewed
(n=1,185) were sent a follow-up questionnaire which
included four focal questions on dental amalgam
and mercury in dentistry.4 One thousand and ten
adults responded. The key findings among dentate
respondents are summarized in Fig 1.
Over one-third (37.5 per cent) expressed concern
about mercury in fillings. Concern significantly
decreased across older age groups and across groups
with increasing numbers of missing teeth. Over 16
per cent reported asking for mercury-free fillings.
Significantly more women than men asked for
mercury-free fillings. Only 5.8 per cent reported
avoiding treatment because of mercury in fillings.
Such avoidance was significantly higher among
those with secondary rather than tertiary education
and household incomes less than or equal to
$30,000. A similar 4.7 per cent reported having
fillings replaced because they contained mercury.
This percentage was significantly higher among
those with one to five missing teeth compared to
those with no teeth or more than six missing teeth.
The high percentage reporting concern and the
sizeable percentage asking for mercury-free fillings
indicate widespread adverse public opinion.That far
fewer people have had mercury fillings replaced may
reflect the influential advice from the majority of
dentists who still regard dental amalgam as the
restorative material of choice in relatively common
clinical circumstances. Even so, 4.8 per cent of the
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Fig 1. – Public opinion on dental amalgam and mercury in dentistry among a random sample
of dentate Australian adults.
Fig 2. – Annual provision of restorative services in Australia; total number of restorative services in
millions and per cent of all dental services.
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Australian adult dentate population represents a
staggering 650,000 people who have had their dental
amalgam fillings replaced.
The placement of dental amalgam fillings
Placing restorations is a major, changing, area of
dental services. There are useful data in Australia to
track changes in dental services over time from the
Longitudinal Study of Dental Practice Activity. This
five-yearly study provides a representative picture of
private general practice from 1983-93.5-7 A related
study, the Study of Dental Services, provides data
for 1997.8 The key trends are illustrated in Fig 2.
From 1983-97, restorative services decreased as a
percentage of all services from 37.5 to 28.8 per cent.
However, as the volume of all provided services
increased, there was a slight increase in the total
number of restorative services provided from 10.7 to
12.4 million a year.
The use of dental amalgam as a material for those
restorative services has deceased markedly. This is
illustrated in Fig 3. In 1983, 57.9 per cent of
restorative services used dental amalgam. By 1997,
the use of dental amalgam had decreased to 28 per
cent of all restorative services. The use of other
restorative materials increased: composite resins
from 25.8 to 40 per cent, glass ionomer cements
from 2.4 to 11.4 per cent and crowns from 3.8 to 14
per cent. Bridges and restorations using other
materials make up the remainder.
While the total number of restorative services
using dental amalgam decreased from 6.1 to 3.5
million, the decrease was not even across all age
groups.9 Estimates of the total number of dental
amalgam fillings placed annually indicated substantial
decreases among 5-11 year olds (0.39 to 0.07
million), 12-17 year olds (0.75 to 0.08 million), 18-
24 year olds (1.33 to 0.19 million) and 24-44 year
olds (2.63 to 1.75 million). For both the middle-age
and older adult age groups, the estimate of the total
number of dental amalgam fillings placed increased
between 1983 and 1997: 25-64 year olds from 0.96
to 1.12 million and 65+ year olds from 0.08 to 
0.20 million. However, for both older age groups,
a peak occurred in 1993 followed by a decrease 
in the placement of dental amalgam fillings through
to 1997.
A further finding was the shift in number of
surfaces involved in restorations.9 There was a
decrease in the percentage of one-surface fillings
from 31.4 to 20.8 per cent across 1983 to 1997.
Two-surface fillings remained at a stable percentage
(47.1 to 46.9 per cent), while three or more surface
fillings increased from 21.5 to 32.3 per cent. There
was a large reduction in the percentage of one-
surface fillings using dental amalgam (57 to 19.5 per
cent), but less dramatic decreases in the percentage
of two-surface fillings (74.4 to 44.5 per cent) and
three or more surface fillings involving dental
amalgam (71.5 to 44.9 per cent).
The placement of restorations is likely to remain
at a similar absolute volume, but a decreasing
percentage, of all dental services. Fewer dental
amalgam fillings are being placed in children,
adolescents and young adults – this reflects both the
overall decline in caries activity in these age groups
and a movement away from dental amalgam toward
composite resins and glass ionomer cements,
Fig 3. – Percentage of restorative services using different materials by time.
especially for one-surface fillings. More dental
amalgam restorations are being placed in late
middle-aged and older adults – this reflects the
higher caries activity and restoration replacement
rates in these now predominantly dentate age groups
and a greater percentage of fillings involving two-
and three-or-more-surfaces where the physical
properties and handling characteristics of dental
amalgam for load bearing fillings on molar teeth are
still frequently regarded as superior to alternative
materials.10
While the annual placement of dental amalgam
fillings may have decreased, many people have
existing dental amalgam fillings. On the basis of an
overall mean of six filled teeth per Australian11 and
50 per cent of those filled teeth being dental
amalgam fillings,12 then there were approximately 50
million dental amalgam fillings in the Australian
community in the later part of the 1980s. This
number will slowly decrease, but there will still be a
large number of dental amalgam fillings in the
Australian population. These trends in the use and
estimates of the burden of dental amalgam for
fillings create the context in which both benefits and
risks need to be considered.
Release of mercury from dental 
amalgam fillings
Given appropriate apportioning of the constituents
of dental amalgam, mixing or trituration, condensing
into the cavity preparation and removal of excess
surface material, it was considered that all available
mercury was bound up in a matrix of mercury-silver-
copper-tin compounds. Further, after the initial set
and hardening of the dental amalgam, it was
considered inert. While it was known that dental
amalgam debris could be swallowed or become
lodged in periodontal tissues, and that corrosion at
the interface with the tooth and abrasion of amalgam
under masticatory load occurred, it was not known
that mercury, in either the vapour or metal ion form,
was released from dental amalgam. However,
dissolution of mercury does occur,13 as illustrated in
Fig 4. Mercury is either released from the material as
metal ions or evaporates to mercury vapour. Metal
ions may pass into the oral fluids to be ingested via the
digestive system – it is suggested that 40 per cent of
mercury exposure from dental amalgam is via
ingestion of metal ions.14 Mercury vapour in the oral
cavity may be exhaled or inhaled into the lungs and
absorbed via the respiratory system – it is suggested
that 60 per cent of mercury exposure from dental
amalgam is via the inhalation of mercury vapour.14
The amount of mercury released will vary with the
number of restorations, their surface area, particularly
the load-bearing surface area, the galvanic currents,
mastication habits (for example, bruxism), eating
habits, chewing gum and toothbrushing habits.
Estimates of mercury released and absorbed initially
varied markedly, but are generally accepted to lie
between 2-5µg/day for the average adult.15-17 On the
assumption that the average Australian adult has
approximately eight teeth with dental amalgam
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Fig 4. – Release of mercury from dental amalgam fillings (adapted from Marek).13
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fillings,11 2-5µg/day exposure to mercury from those
fillings is in keeping with data published by
Richardson and Allan.14 However, on the assumption
that a 12 year old child has only 0.5 tooth with a
dental amalgam filling,11 exposure would be about
0.3µg/day.
In recognizing the release and absorption of
mercury from dental amalgam fillings, it is important
to place this absorption in the context of total
mercury absorbed per day. The most recent
Australian data on dietary mercury estimated the
average daily intake of dietary mercury in food at
15µg.18 Approximately 40 per cent of dietary
mercury will be bio-available,19 indicating that
absorbed dietary mercury will be approximately
5.8µg/day. Mercury from dental amalgam fillings
represents an average 25-50 per cent of total mercury
absorbed per day. This is comparable to other
reports.14 For a 12 year old child, average dietary
mercury intake is about 8µg/day, with absorbed
dietary mercury approximately 3.2µg/day and
mercury from dental amalgam fillings make up
about 9 per cent of total mercury absorbed per day.
Mercury absorption and adverse health effects
Mercury vapour is rapidly absorbed in the
respiratory tract and distributed by blood to a
number of key target organs. Mercury vapour is
oxidized to inorganic mercury and elimination is by
exhaled air or as inorganic mercury by urine from
the kidneys, sweat and saliva. The key target organs
are the central nervous system, which appears to be
the most sensitive toxicological endpoint observed
following exposure to mercury vapour, and the
kidneys. Inorganic mercury (metal ions) is much less
readily absorbed in the gastrointestinal tract.
Approximately 15-20 per cent of available inorganic
mercury may be absorbed,20 hence the majority of
ingested inorganic mercury is excreted through the
faeces. Inorganic mercury has limited capacity to
penetrate blood-brain or placental barriers, thus the
most sensitive toxicological endpoint observed
following exposure to inorganic mercury is kidney
function.
There is a reasonable understanding of the
pharmacokinetics of mercury, its absorption,
distribution and elimination.20 It is also clear that
very high levels of mercury absorption, for instance
urinary levels of mercury above 100µg/g creatinine,
are associated with adverse health effects,
predominantly with the central nervous system and
the kidneys. What is less certain is the level of
mercury absorption at which the first adverse effects
occur or whether the level of mercury absorbed from
dental amalgam fillings leaves some appropriate
safety margin for the lowest level of exposure to
mercury with an established adverse health effect.
In considering dental amalgam and mercury in
dentistry, three lines of investigation are relevant to
the issue of adverse health effects:
1. Is the presence of dental amalgam fillings
associated with signs or symptoms of adverse health
effects?
2. Is the removal of dental amalgam fillings
associated with better health outcomes?
3. Can risk assessments establish that the level of
mercury absorbed from dental amalgam fillings
leaves an adequate safety margin for the lowest level
of mercury exposure with an adverse health effect?
These questions are considered below.
Dental amalgam fillings and signs and
symptoms of adverse health effects
The claimed association between dental amalgam
fillings and a range of diseases or symptoms of
unknown aetiology has been the starting point for
much concern over mercury absorption from dental
amalgam.21 A long list of possible adverse symptoms
has been incorporated into questionnaires for
practitioners to use. Certainly patients with dental
amalgams do report symptoms such as irritability,
depression, numbness and tingling in the extremities,
frequent night urination, chronic fatigue, cold hands
and feet, bloating, memory loss, anger and
constipation. However, this does not establish
causation.
The problem with observing symptoms of
unknown aetiology in patients with dental amalgam
restorations is confusing commonality with causality.
Both the symptoms and dental amalgam fillings are
commonplace, thus one being observed with the
other is not unexpected. This is what one researcher
called the menace of daily life.22 Further, the
selection of practitioners who have an ‘amalgam-free
practice’ by patients who have such symptoms and
think their dental amalgam fillings may be the cause,
only accentuates the apparent commonality.
A much higher level of evidence about causality is
required.The basis for much of this consideration of
evidence was developed by Hill23 and has been
applied to commonplace exposures.24 More recently,
a hierarchy of strength of evidence for clinical inter-
ventions has been adopted by the National Health
and Medical Research Council and this can also
guide the assessment of evidence on causality.25
Stronger evidence can only come by moving away
from one-time reports of a series of ‘cases’ to more
complex designs. A small step forward is made in
cross-sectional comparisons of a sub-sample of the
population with and without (or with few) dental
amalgam fillings. This was the approach of Ahlqwist
et al who compared the prevalence of 30 specified
symptoms and complaints in dentate women with
equal to or greater than 20 and 0-4 tooth surfaces
with dental amalgam fillings.26 They found no
symptom or complaint to be more common in those
with higher numbers of dental amalgam fillings.
Instead, chest pain, over-exertion, abdominal pain,
poor appetite and loss of weight were significantly
less common in those with more tooth surfaces filled
with dental amalgam. A similar study by Saxe et al
among US nuns found no association between
dental amalgam surface area and eight different tests
of cognitive function.27
Studies like those by Ahlqwist et al can be further
improved to support or refute causality. Their cross-
sectional design leaves the issue of time precedence
unaddressed. The next higher level of evidence on
the link between dental amalgam fillings and adverse
health effects would be cohort studies, where
individuals exposed and not exposed to dental
amalgam fillings are measured and followed over
time for a range of adverse health effects. Even
higher level evidence comes from randomized
controlled trials. Here, the use of dental amalgam for
fillings is on a random basis.This reduces the risk of
bias in who receives and does not receive dental
amalgam fillings. However, the issue of participants
knowing whether they receive dental amalgam
fillings or not remains problematic. Alternatively, a
randomized controlled trial could be conducted on
the removal of dental amalgam fillings from patients
with claimed mercurialism. This leads into the
second type of evidence, the outcome of the removal
of dental amalgam fillings.
Health outcomes after the removal of 
dental amalgam fillings
When a patient claims symptoms or complaints
caused by mercurialism from dental amalgam
fillings, some practitioners remove the amalgam
fillings. Detailed protocols have been developed for
the removal process to protect the patient, dentist
and staff from what would otherwise be a high single
mercury exposure. Protocols involve rubber dam,
evacuation behind the dam, special systems for
evacuation over the tooth, cutting away rather than
drilling out the dental amalgam filling, rinsing the
working area with water, shielding, oxygen-rich air
supplies, filters and negative ion generators. Staging
and timing of removal by quadrants is considered
important. Adjunctive therapies are also common –
these include chelation agents to reduce body load
of mercury and nutritional support involving zinc,
vitamin C, antioxidants and other preparations.2
It has been reported that high percentages of
patients with symptoms or complaints claimed to be
from mercurialism show improvements as a result of
dental amalgam filling removal. Equally, dramatic
testimonies are available from individuals whose
lives appear to be changed by their dental amalgam
filling removal. However, the circumstantial
evidence should be examined as such case reports
frequently lack independent, objective assessment.
There is a strong likelihood of non-specific treat-
ment (placebo) and undefined effects from the
adjunctive therapies. After removal, when a high
number of symptoms and complaints are generally
being monitored, the probability that some patients
will improve by chance alone is high. The long-term
benefits are unknown as follow-up is often 
short-term and incomplete.2
While dental amalgam removal does lead to
reduced mercury concentrations in blood and urine,
no differences have been observed in organ function
before and after amalgam filling removal.28 In
Sweden, a three-year follow-up study of dental
amalgam removal among people claiming
mercuralism found the amalgam removal did not
result in any significant effect on general health.29
Overall, there is a lack of supportive scientific
evidence of improved health outcomes following
removal of dental amalgam fillings.30
The efficacy of the adjunctive therapies, especially
chelation agents such as dimercapto-propane sulfonate
(DMPS) or 2,3 dimercapto-succinic acid (DMSA),
is a separate issue. Concern has been expressed
about the efficacy and safety of these agents,2 as
there are few higher level studies on their use.
Grandjean et al, in a randomized clinical trial
involving 50 patients who claimed mercurialism
symptoms or complaints, showed no difference in
health outcome between active and placebo
chelation treatment groups.31 Another trial of 23
patients undergoing dental amalgam filling removal
showed no benefit of a chelating agent compared
with a placebo and was terminated prematurely due
to the occurrence of hypersensitivity to the chelation
agent.32 Clearly, care is required in the use of
chelating agents.
The mix and proportions of mercury absorption
from different sources present a potentially
confounding problem in establishing either a causal
association between the presence of dental amalgam
fillings and various symptoms and complaints or
improved health outcomes upon their removal.
Earlier estimates were that mercury absorption from
dental amalgam fillings may be as low as 25-50 per
cent of total mercury absorbed daily in an adult.
Unless patients undergo marked dietary changes
away from a range of fish and seafoods, green
vegetables and other foods, total mercury absorption
per day is likely to remain high. Researchers will
need to take account of the confounding effect of
other mercury exposures.
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Risk assessment
The third area of investigation concerning the
possible adverse health effects of mercury from
dental amalgam fillings is formal toxicological risk
assessment. Risk assessment initially focuses well
away from the direct clinical or epidemiological
study of individuals with dental amalgam fillings to
the area of occupational exposures.
Risk assessment involves four processes: hazard
identification, dose-response assessment, exposure
assessment and risk characterization.33,34
Mercury has a long history as an identified health
hazard.There is no doubt that mercury at high levels
of absorption causes severe adverse health effects.
Attention then shifts to the dose-response assess-
ment, essentially to answer the question of the
effects of low levels of mercury absorption. Two
points on the dose-response curve crucial to risk
assessment are illustrated in Fig 5.33 The first is the
level of dose up to which no adverse health effect is
observed – a No Observed Adverse Effect Level
(NOAEL) – and the second is the level of dose down
to which an adverse health effect is observed – a
Lowest Observed Adverse Effect Level (LOAEL).
Which of these is known is subsequently important
in establishing an uncertainty factor, because a
factor of 10 is assumed in extrapolating a LOAEL to
a NOAEL if a NOAEL is not known. Other
uncertainty factors can also be applied, for instance
for assumed variation in sensitivity in the population.
Toxicologists use the NOAEL or LOAEL divided by
uncertainty factors to estimate a Tolerable Daily
Intake (TDI). A level of mercury absorbed from
dental amalgam fillings which exceeds the TDI
would raise concerns but does not imply that an
adverse effect will occur. Public policy might have to
weigh those concerns against any possible benefits
from the exposure, for example, the restoring of
tooth function and avoidance of pain and suffering
through the use of the material when alternatives are
not either available or as cost-effective.
Exposure to low levels of mercury in air can be an
occupational hazard in a number of industries.While
traditionally these have included industrial sites such
as chloralkali factories,35 there is now an increasing
trend to assess risk of exposure to mercury in dental
office staff.36
There are numerous methodological issues in
such research that add confusion and disquiet.2
First, such studies are frequently case:control studies.
In terms of the evidence provided, case:control
studies are considered to be of a low quality because
there is no researcher control over who is a case or
control (individuals with and without exposure to
mercury). In a factory, cases may be the less educated
or skilled, possibly interfering with measurement of
neurobehavioural health effects. Case:control type
studies are one-time snapshots, so there can be
doubt whether the health effect preceded or followed
exposure or the length and level of exposure.
Second, there are many end-points which might be
selected to represent an adverse health effect. The
most sensitive systems or organs for mercury
exposure are thought to be the central nervous
system or kidney, but what specific change or end-
point should be used? Most end-points are not clear
Fig 5. – Dose-response relationship between mercury exposure and effects, illustrating the key toxicological




clinical health changes, but subtle signs of function
that may or may not be indicative of an adverse
health effect. An example is the release of N-acetyl-
ß-glucose amidase (NAG) in urine which has been
variously regarded as a biomarker of exposure to
mercury37 through to an indicator of impaired renal
function.38 Third, many end-points are not only
affected by mercury but many other heavy metals or
substances. Is exposure to other possible risks
known and appropriately accommodated for in any
analysis? Fourth, there can be difficulty in equating
an occupational exposure to mercury in air (µg/m3)
to exposure to mercury from dental amalgam fillings
(µg/l urine or µg/g creatinine).
This is not an exhaustive list of the methodological
issues. However, it serves as a rationale for why some
groups have been unwilling on the basis of available
research to even estimate a TDI and why there is
debate when particular research results are used.39
This occurred after Richardson40 used Fawer et al’s35
research on hand tremor among chloralkali factory
workers.32 The debate about the quality of the
evidence will continue; however, there is increasing
research activity on occupational exposure to
mercury especially among dentists and their office
staff.36 This will make the systematic review of such
research crucial and it will also ensure that risk
assessments become common.
Interpretation of risk assessments 
for public policy
Even if risk assessment helps provide a clearer
picture on low level exposure to mercury and
adverse health effects, the way forward to public
policy on the use of dental amalgam in dentistry is
not straightforward. Two issues that need to be
addressed pull policy in different directions –
variation in sensitivity and cost-benefit, especially in
comparison with alternatives.
Risk assessment, like most population research,
seeks to derive a general understanding; however,
individuals will vary in their sensitivity to exposure
to mercury. In a quantitative sense, this is
accommodated by applying an uncertainty factor to
the findings available from research among adults.
However, there is an as yet unquantifiable, but
accepted, variation in sensitivity among certain
population subgroups – foetuses (and, therefore,
pregnant women) and the young developing child.
As a matter of principle, the higher sensitivity of the
developing foetus or child takes on special
significance in framing prudent public policy.
Hence, beginning with Health Canada,39 a number
of bodies and reports have recommended that
exposure to mercury from dental amalgam fillings
be minimized whenever possible by using alternative
materials in the teeth of children and not placing or
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Fig 6. – Mercury cycle and environmental mercury sources in dentistry (after Horsted-Bindslev et al).50
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removing dental amalgam fillings in the teeth of
pregnant women.2,41,42 Further, because mercury may
not be eliminated well, dental amalgam fillings are
best avoided for people with impaired kidney
function.2,39 However, such recommendations reflect
prudent or cautious approaches and not direct
evidence of any harm.2,39,41-43 The criterion of ‘when-
ever possible’ is also crucial. These recommendations
accept that dental amalgam fillings should still be
used when clinical circumstances indicate no
alternative material is available.
The benefit of the use of dental amalgam fillings
is a counterbalancing factor. Such a benefit cannot
be judged in the absolute sense against no filling
being placed, but in a relative sense against the
alternative filling materials. While there has been
great technological development in composite resin
and glass ionomer cement materials, it is generally
accepted they both have higher initial cost and shorter
longevity;10,44-46 however, relative risks also need to be
entertained. Very little research has been published
on the toxicology of either composite resins or glass
ionomer cements,47-49 and this needs to be rectified as
it would be shortsighted policy to encourage a move
from the use of dental amalgam to alternative
materials that later may be found to present their
own risks.
Other issues surrounding mercury which
impinge on dental amalgam fillings
The Australian focus on the use of dental
amalgam fillings has been strongly individualistic.
The concern has been with the risks and benefits to
the individual in whose teeth dental amalgam fillings
have been placed. This is in contrast to two wider,
collective concerns about mercury.
First, the mercury cycle in dentistry,50 as illustrated
in Fig 6, describes the pathways by which surplus
triturated or carved dental amalgam along with
minor particles of removed old dental amalgam
fillings may be evacuated to waste in a dental
practice. Depending on the fate of such waste, for
example the presence of amalgam separators, there
can be concern over the dental amalgam entering
drains or the sewage system. Extracted teeth with
dental amalgam fillings contribute to solid waste and
dental amalgam fillings in deceased people are
disposed of in the process of interment or cremation.
Through these pathways, an individual’s dental
amalgam fillings can contribute to environmental
mercury exposure. In Scandinavia and Europe,
considerable concern about dental amalgam fillings
has its genesis in this environmental exposure to
mercury.51,52
Second, there is a heightened concern about
exposure to mercury in the food chain, particularly
methylmercury from fish and seafoods. Recent
downward-revised TDI or RfD estimates from the
US Environmental Protection Agency indicate a
trend toward lower levels of exposure being linked to
adverse health effects.53,54 These estimates reflect
community concern about mercury in general and
will ensure dental amalgam fillings remain a
contentious community issue for the foreseeable
future.
As a consequence, patients will continue to raise
their concerns with dentists, so there is a need for
dentists to provide concise, authoritative information
to their patients. With the changed emphasis on
patient autonomy and informed consent, all dentists
will need to inform, advise and then support their
patients in choices made about the use of restorative
materials, including dental amalgam.2
Conclusion
A minority of the public has expressed concern
about the use of dental amalgam in dentistry. While
dental amalgam use has decreased markedly overall
and in age groups up to late middle-aged adults, a
vast number of dental amalgam fillings exist in the
population. Mercury is released at very low levels
from dental amalgam fillings and mercury vapour is
absorbed in the lungs and inorganic mercury is
absorbed in the gastrointestinal tract. However,
there is no evidence that mercury absorbed from
dental amalgam fillings is associated with signs or
symptoms of adverse health effects or that the
removal of dental amalgam fillings is associated with
better health outcomes. Risk assessments, while
clouded with uncertainty, have not established an
inadequate safety margin between the level of
mercury absorbed from dental amalgam fillings and
the lowest levels associated with adverse health
effects among people with occupational exposure to
mercury. Despite this lack of evidence, it is a
principle in toxicology to accept there are more
sensitive groups in the community, especially foetuses
and young children, and as a result to recommend
minimization of exposure among pregnant women
and young children. The trend in dental amalgam
use is toward minimization, but there is still wide-
spread opinion that dental amalgam is the material
of choice in certain clinical situations. This clinical
benefit and the lack of risk assessments of alternative
materials are counterbalancing factors in the
continued use of dental amalgam. However,
wider environmental issues with dental amalgam use
and disposal and increasing concern over
methylmercury exposure will maintain community
concerns. Dentists and their patients will need to be
well informed and patient autonomy and choice
respected.
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